Edition:
India

Aravive Inc (ARAV.OQ)

ARAV.OQ on NASDAQ Stock Exchange Global Select Market

5.35USD
2:29am IST
Change (% chg)

$0.13 (+2.49%)
Prev Close
$5.22
Open
$5.29
Day's High
$5.35
Day's Low
$5.21
Volume
7,972
Avg. Vol
9,655
52-wk High
$15.15
52-wk Low
$3.07

Latest Key Developments (Source: Significant Developments)

Aravive Presents Detailed Results Of Phase 1 Clinical Trial Of AVB-S6-500 At The 2018 EORTC-NCI-AACR Symposium
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Aravive Inc ::ARAVIVE PRESENTS DETAILED RESULTS OF PHASE 1 CLINICAL TRIAL OF AVB-S6-500 AT THE 2018 EORTC-NCI-AACR SYMPOSIUM.ARAVIVE INC - PHASE 1 CLINICAL TRIAL IN HEALTHY VOLUNTEERS DEMONSTRATED THAT AVB-S6-500 WAS WELL TOLERATED WITH AN ACCEPTABLE SAFETY PROFILE..ARAVIVE INC - THERE WERE NO SERIOUS ADVERSE EVENTS (AES) AND AVB-S6-500 WAS WELL TOLERATED ACROSS ALL DOSES.  Full Article

Versartis Q1 Loss Per Share $0.25
Wednesday, 9 May 2018 

May 8 (Reuters) - Versartis Inc ::VERSARTIS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.25.CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS WERE $74.7 MILLION AS OF MARCH 31, 2018.  Full Article

Versartis reports Q3 loss $1.40/shr
Friday, 27 Oct 2017 

Oct 26 (Reuters) - Versartis Inc :Versartis reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $1.40.Q3 earnings per share view $-0.71 -- Thomson Reuters I/B/E/S.  Full Article